WHO Global Summit charts a bold future for traditional medicine
The WHO Global Summit on Traditional Medicine, co-organized with the Government of India, concluded in New Delhi. The e…
The WHO Global Summit on Traditional Medicine, co-organized with the Government of India, concluded in New Delhi. The e…
Analysis of post-discharge outcomes demonstrates that trazodone significantly reduces both rehospitalization rates and…
vCATCH technology achieves single-cell resolution mapping of covalent drug binding sites across intact mammalian tissue…
The UN agencies have welcomed the news that the threat of famine in the Gaza Strip has been averted, following the Octo…
Diallyl sulfides—natural compounds abundant in garlic—extended lifespan and improved multiple aging markers in male mic…
The World Health Organization (WHO) has validated Brazil for eliminating mother-to-child transmission of HIV, making it…
Eliminating alcohol consumption produces measurable physiological improvements within weeks, with cardiovascular marker…
A validated frailty index—measuring accumulated deficits across multiple body systems—emerged as a stronger predictor o…
The World Health Organization (WHO) is hosting the Second Global Summit on Traditional Medicine, in collaboration with…
The World Health Organization reports that world leaders have adopted a historic global declaration to address noncommu…
University of South Florida researchers identified elevated omega-6 fatty acid concentrations within colorectal tumor t…
Escalating doses of metformin in diabetic mice revealed that the drug's glucose-lowering effects correlate directly wit…
New analysis reveals that the temporal sequence in which heart failure and atrial fibrillation emerge significantly inf…
The WHO's expert group has conducted a new analysis that reaffirms the lack of a causal link between vaccines and autis…
A large randomized trial comparing ketamine versus etomidate for emergency intubation in critically ill patients found…
Trastuzumab deruxtecan demonstrated superior invasive disease-free survival compared to standard trastuzumab in patient…
The combination of teclistamab and daratumumab produced a 71% overall response rate in patients with heavily pretreated…
A phase 2 trial combining ianalumab, a monoclonal antibody targeting CD20-positive B cells, with eltrombopag, a thrombo…
A multicountry clinical trial found that structured group music sessions provided no sustained improvement in depressiv…
Get daily health research summaries delivered to your inbox.
Browse our synthesized research summaries by topic. We cover the latest findings from journals like Nature Medicine, The Lancet, Cell Metabolism, and 100+ other peer-reviewed sources.